America’s Behavioral Health Crisis Is Worsening, New Statistics Suggest

The demand for behavioral health services continues to outpace the supply of services. In particular, the demand for eating disorder and anxiety disorder treatment has grown significantly since 2019, according to a new report by Trilliant Health. For example, the visit volume for eating disorders has increased by 52.6% from 2019 to 2022. Additionally, visit […]

How Health Care Vet Cassie McLean Is Building an Eating Disorder Treatment Powerhouse at Monte Nido & Affiliates

After naming a new CEO and changing ownership in late 2022, eating disorder provider Monte Nido & Affiliates is set on growing its footprint while expanding access to its services. To execute that mission, the private equity-backed company has tapped health care veteran Cassie McLean, who has worked in the sector for decades, most recently […]

Why the Digital Behavioral Health Industry Needs Consolidation

A new PitchBook report predicts that the digital health sector should expect — and even needs — greater consolidation to succeed. And behavioral health will see a significant role in that movement as it continues to drive the continued use of digital health in the U.S. However, behavioral health providers will need to consider doing […]

Cerebral Reveals It Shared Patient Health Information with Third-Party Advertisers, Social Media Companies

Embattled behavioral health company Cerebral revealed that its users’ private health information was shared with third-party advertisers and social media companies. Cerebral posted a “Notice of HIPAA Privacy Breach” on its website earlier this week explaining that it uses “pixels” and similar common technologies from tech giants Google, Facebook, and TikTok. The telehealth unicorn noted […]

A Group of Lawmakers Want to Make It Easier for Psychedelic Research, Compassionate Use

A group of federal lawmakers seeks to remove regulatory barriers that inhibit psychedelics in research and compassionate use cases. Senators Cory Booker (D-N.J.) and Rand Paul (R-KY) introduced an updated version of the Breakthrough Therapies Act to the Senate. If passed, the bill would make it easier to use Schedule 1 drugs with a breakthrough […]

LifeStance Pulling Back on M&A, Ready to Put Hybrid Model to Work Post-PHE

LifeStance (Nasdaq: LFST) is pulling back from its expansion efforts as it refocuses its goal on long-term profitability. The sizable behavioral health provider plans to do this by consolidating brick-and-mortar facilities, cutting payer contracts by 25% and pulling back on its M&A strategy, instead opting for more organic growth. The company has its sights set […]

Lawmakers Push for More At-Home Methadone Prescriptions

Federal lawmakers introduced a new bill that would loosen regulations on methadone prescribing. Legislators released the Modernizing Opioid Treatment Access Act in the U.S. House of Representatives and the Senate. A bipartisan group announced the bill, saying it would be vital in expanding care for opioid use disorder (OUD). “This legislation lowers barriers to care […]

How Delphi Behavioral Health Group Went From Boom to Bust

New documents reveal how Delphi Behavioral Health Group went from boom to bust. After two rounds of private equity backing, shrinking payer rates for out-of-network substance use disorder care squeezed the Fort Lauderdale, Florida-based addiction treatment provider out of business. The soon-to-be-defunct Delphi Behavioral Health Group first revealed its demise in late January. It told […]

Inside CareFirst’s New SUD-Focused Partnership with Navigator Healthcare

CareFirst BlueCross BlueShield is joining forces with Navigator Healthcare on a new partnership aimed at helping members find appropriate care for substance use disorder (SUD). As part of the deal, CareFirst’s members can call the Navigator Healthcare team 24/7 to help them find the proper, in-network care for their SUD needs. The collaboration reflects the […]

It’s Not ‘Magic’: Ending the X-Waiver Alone Unlikely to Fix MAT’s Access Problem

The federal government now allows any appropriately registered prescribers to use buprenorphine to treat patients with opioid use disorder (OUD) after years of loosening restrictions on the drug. Several behavioral health insiders see the move as having clear benefits for the industry. However, the benefit of deregulating buprenorphine may underwhelm in the short-term and even […]